Vaxart Up on Pre-Clinical Data on Coronavirus Vaccine Candidates
Vaxart's (VXRT) several COVID-19 vaccine candidates generate immune responses in pre-clinical studies. Stock rises.
finance.yahoo.com
* This article was originally published here
Aucun commentaire:
Enregistrer un commentaire